Millet I, Lafont S, Jeannin M, Revillard J P, Normier G, Dussourd d'Hinterland L
Laboratoire d'immunologie, Inserm U80 CNRS UA 1177, Hôpital E.Herriot, Lyon, France.
Int Arch Allergy Appl Immunol. 1988;86(4):432-5. doi: 10.1159/000234630.
The in vitro lymphocyte-activating properties of a ribosomal preparation of Streptococcus pyogenes were investigated. The preparation was mitogenic for human lymphocytes with a peak of 3H-thymidine incorporation occurring after 3-5 days of culture. The response was abolished by removal of CD3-positive cells and by alteration of accessory cells by exposure to L-leucine methyl ester. Most of the cells synthesizing DNA at the end of the culture expressed CD4 or CD8 but not CD20 antigens. No immunoglobulin synthesis was demonstrable. Although the same preparation was shown to be a T-independent polyclonal B-cell activator of murine cells, it preferentially triggers T cells in humans.
研究了化脓性链球菌核糖体制剂的体外淋巴细胞激活特性。该制剂对人淋巴细胞具有促有丝分裂作用,在培养3 - 5天后出现3H - 胸腺嘧啶核苷掺入峰值。去除CD3阳性细胞以及通过暴露于L - 亮氨酸甲酯改变辅助细胞后,反应消失。培养结束时大多数合成DNA的细胞表达CD4或CD8抗原,但不表达CD20抗原。未检测到免疫球蛋白合成。尽管相同制剂已被证明是小鼠细胞的非T细胞依赖性多克隆B细胞激活剂,但它在人类中优先触发T细胞。